Alternative activation of mast cells by CD4+ T helper cells
Journal of Leukocyte Biology · 2024
DOI: 10.1093/jleuko/qiae139 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Leukocyte Biology, 2024. Verfasst von Edouard Leveque und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche U1037, Centre de Recherche en Cancérologie de Toulouse, 2 Avenue …. Hauptthemen laut MEDLINE: Mast Cells, T-Lymphocytes, Helper-Inducer. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Gefördert von: Laboratoire d'Excellence Toulouse Cancer, Ligue Nationale contre le Cancer, French Ministry of Education and Research.
Abstract (Originalsprache)
Effector CD4+ T (Teff) lymphocytes infiltrate sites of inflammation and orchestrate the immune response by instructing local leukocytes. Mast cells (MCs) are tissue sentinel cells strategically located near blood vessels and T cell–rich areas. MC/Teff cell interactions shape Teff cell responses, but in turn, Teff cell action on MCs is still poorly understood. Here, we analyzed the human MC/Teff cell interplay through both the application of RNA sequencing and functional assays. We showed that activated Teff cells induce a specific transcriptomic program in MCs including production of both inflammatory cytokines and chemokines, prostaglandin, and a FcεRI-dependent degranulation facilitation, thereby driving them toward an inflammatory phenotype. Moreover, Teff cells induce in MCs the capacity to interact with CD4+ T cells through a wide range of dedicated soluble and membrane ligands and to play the role of antigen-presenting cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche U1037, Centre de Recherche en Cancérologie de Toulouse, 2 Avenue H. Curien, F-31037, France.
- Université Toulouse III - Paul Sabatier, 118 route de Narbone, Toulouse F-31062, France.
- Institut National de la Santé et de la Recherche Médicale, U1220, Institut de Recherche en Santé Digestive, Institut National de la Recherche Agronomique, Institut National Polytechnique de Toulouse-École Nationale Vété…
- Department of Pathology, Institut Universitaire du Cancer-Oncopole de Toulouse, Centre Hospitalier Universitaire de Toulouse, 1 avenue Irène Joliot-Curie, Toulouse F-31059, France.
ORCID-Profile: Eric Espinosa
Förderung
- Laboratoire d'Excellence Toulouse Cancer
- Ligue Nationale contre le Cancer
- French Ministry of Education and Research
- ANR
Zitieren
APA
Leveque, E., Battut, L., Petitfils, C., Valitutti, S., Cenac, N., Dietrich, G., & Espinosa, E. (2024). Alternative activation of mast cells by CD4+ T helper cells. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae139
Vancouver
Leveque E, Battut L, Petitfils C, Valitutti S, Cenac N, Dietrich G, et al. Alternative activation of mast cells by CD4+ T helper cells. Journal of Leukocyte Biology. 2024. doi:10.1093/jleuko/qiae139
BibTeX
@article{Leveque2024,
author = {Leveque, Edouard and Battut, Louise and Petitfils, Camille and Valitutti, Salvatore and Cenac, Nicolas and Dietrich, Gilles and Espinosa, Eric},
title = {Alternative activation of mast cells by CD4+ T helper cells},
journal = {Journal of Leukocyte Biology},
year = {2024},
doi = {10.1093/jleuko/qiae139}
}
EUVIMED